BPA plus CTEPH medicines to improve heart strain
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether starting specific medicines for CTEPH and then doing balloon pulmonary angioplasty (BPA) can improve how well the right side of the heart is working. It may help people who cannot have surgery (PTE) and are newly starting CTEPH/PAH-targeted treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed diagnosis of CTEPH (a blood-clotting problem in lung arteries)
- You are not a candidate for PTE surgery
- Your specialist says BPA is possible for you based on your scan anatomy and disease severity
- You have not started CTEPH/PAH-specific medicines before, and you plan to start them as part of the study
- You can consent, follow the schedule, and complete study procedures (including MRI if required)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a minimally invasive procedure called balloon pulmonary angioplasty (BPA) helps patients with chronic blood clots in the lungs improve their heart function and overall recovery. Researchers will measure blood flow patterns in your arteries before and after the procedure to understand how well your heart recovers.
This study uses special heart scans (CMR with 4D flow) to see how a procedure called BPA affects blood flow in the heart and lungs for people with a rare type of high blood pressure in the lungs (CTEPH). It may help doctors understand how well BPA works beyond just symptoms.
This trial tests whether patients with chronic thromboembolic pulmonary hypertension who have improved after a procedure called balloon pulmonary angioplasty can safely stop taking the drug riociguat, or whether they should continue it. The goal is to learn whether stopping the medication is safe or if staying on it prevents symptoms from returning.
This trial tests if a supervised exercise and education program (pulmonary rehabilitation) can improve quality of life and daily health for people with pulmonary hypertension. It may help you breathe easier, feel stronger, and manage daily activities better.
This trial is for people with a type of long-term blood clot in the lungs (CTEPH) who have been taking riociguat for at least 12 weeks. It will see what happens when the medication is stopped, focusing on how the right side of the heart is doing.
This trial tests switching from sildenafil to a newer medicine called riociguat for people with CTEPH (a type of lung blood pressure problem) who still have symptoms after a balloon procedure. The goal is to see if the switch helps them feel better.
Hear when a new CTEPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.